[
  {
    "ts": null,
    "headline": "Colgate-Palmolive earnings, consumer sentiment: What to Watch",
    "summary": "Here's what investors are watching on Friday, April 25. Colgate-Palmolive (CL), SLB (SLB), Charter Communications (CHTR), and AbbVie (ABBV) are set to report earnings. The final consumer sentiment estimate for April will be released in the morning with economists expecting 50.6, a slight decline from 50.8. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
    "url": "https://finnhub.io/api/news?id=a0a03f43d8b19d5fe7fddd96f1a4e21c51cc1c4b0e02e4a8863938bc20ce853d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745535600,
      "headline": "Colgate-Palmolive earnings, consumer sentiment: What to Watch",
      "id": 134067455,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Here's what investors are watching on Friday, April 25. Colgate-Palmolive (CL), SLB (SLB), Charter Communications (CHTR), and AbbVie (ABBV) are set to report earnings. The final consumer sentiment estimate for April will be released in the morning with economists expecting 50.6, a slight decline from 50.8. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
      "url": "https://finnhub.io/api/news?id=a0a03f43d8b19d5fe7fddd96f1a4e21c51cc1c4b0e02e4a8863938bc20ce853d"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock rises Thursday, still underperforms market",
    "summary": "AbbVie Inc. stock rises Thursday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=b3419379f4a2effbb736898efada6efdb7610dcdff3ea6b1395c440bd68a2515",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745512320,
      "headline": "AbbVie Inc. stock rises Thursday, still underperforms market",
      "id": 134071902,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock rises Thursday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=b3419379f4a2effbb736898efada6efdb7610dcdff3ea6b1395c440bd68a2515"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines",
    "summary": "AbbVie (NYSE: ABBV) today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE) for the treatment of moderate to severe glabellar lines.",
    "url": "https://finnhub.io/api/news?id=979e5ec8f96b2fe1ce710e8f571f730944eddd594f520cc24795fdb9b6ed195e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745497800,
      "headline": "AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines",
      "id": 134059315,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE: ABBV) today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE) for the treatment of moderate to severe glabellar lines.",
      "url": "https://finnhub.io/api/news?id=979e5ec8f96b2fe1ce710e8f571f730944eddd594f520cc24795fdb9b6ed195e"
    }
  },
  {
    "ts": null,
    "headline": "Merck (MRK) Q1 Earnings and Revenues Top Estimates",
    "summary": "Merck (MRK) delivered earnings and revenue surprises of 3.26% and 0.93%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=35cebcd6a20cc40677c511a3d9405f802f32e728a2fc13171a48d5269375f454",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745494807,
      "headline": "Merck (MRK) Q1 Earnings and Revenues Top Estimates",
      "id": 134059316,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Merck (MRK) delivered earnings and revenue surprises of 3.26% and 0.93%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=35cebcd6a20cc40677c511a3d9405f802f32e728a2fc13171a48d5269375f454"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie (ABBV) Reports Earnings Tomorrow: What To Expect",
    "summary": "Pharmaceutical company AbbVie (NYSE:ABBV) will be reporting earnings tomorrow before market open. Here’s what investors should know.",
    "url": "https://finnhub.io/api/news?id=d3df9626104444047033cd88d3aefad1eca78482691e6e5605bbdd31e3e193a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745478069,
      "headline": "AbbVie (ABBV) Reports Earnings Tomorrow: What To Expect",
      "id": 134063848,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Pharmaceutical company AbbVie (NYSE:ABBV) will be reporting earnings tomorrow before market open. Here’s what investors should know.",
      "url": "https://finnhub.io/api/news?id=d3df9626104444047033cd88d3aefad1eca78482691e6e5605bbdd31e3e193a7"
    }
  },
  {
    "ts": null,
    "headline": "The Gross Law Firm Reminds Cerevel Therapeutics Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - ABBV",
    "summary": "NEW YORK, April 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. . ...",
    "url": "https://finnhub.io/api/news?id=c4766f394e01c018eb7ad0d00c36eaf1102d7299838f63250af99b5817e13e52",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745473578,
      "headline": "The Gross Law Firm Reminds Cerevel Therapeutics Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - ABBV",
      "id": 134057663,
      "image": "",
      "related": "ABBV",
      "source": "Finnhub",
      "summary": "NEW YORK, April 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. . ...",
      "url": "https://finnhub.io/api/news?id=c4766f394e01c018eb7ad0d00c36eaf1102d7299838f63250af99b5817e13e52"
    }
  }
]